Genetic Technologies (GENE) Fails to deliver data

Key failure to deliver metrics for Genetic Technologies:

• Last SEC data release: 2025-09-30
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last 12 months FTD volume: A$0 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Genetic Technologies (GENE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Genetic Technologies (GENE) - since 2023

Genetic Technologies (GENE) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Eterna Therapeutics ERNA	N/A	A$2.11 M	🇺🇸 USA
Myriad Genetics MYGN	A$0.07 M	A$0.95 M	🇺🇸 USA
LabCorp LH	A$14.74 M	A$33.36 M	🇺🇸 USA
Quest Diagnostics DGX	A$22.12 M	A$37.65 M	🇺🇸 USA
Compugen CGEN	A$0.2 M	A$0.73 M	🇮🇱 Israel
Danaher DHR	A$35.49 M	A$0.11 B	🇺🇸 USA
Thermo Fisher Scientific TMO	A$26.73 M	A$78.59 M	🇺🇸 USA
Neogen NEOG	A$13.08 M	A$29.15 M	🇺🇸 USA